Form 4: Edwards Lifesciences CFO Scott Ullem Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Scott Ullem, CFO of Edwards Lifesciences, executed a stock option exercise and subsequent sale of shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 29, 2024, Scott B. Ullem, the Chief Financial Officer of Edwards Lifesciences Corp, exercised stock options to acquire 7,255 shares of common stock at a price of $36.75 per share.
- Simultaneously, Ullem sold 7,255 shares of common stock at a weighted average price of $85.5855 per share, with prices ranging from $85.02 to $86.00.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 5, 2023.
- Following these transactions, Ullem directly owns 19,074 shares and indirectly owns 266,318 shares through a trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports routine stock transactions under a pre-existing trading plan. There is no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's outlook or performance. It is common for executives to have pre-arranged trading plans to manage their stock holdings.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they represent routine insider trading activity under a pre-arranged plan.
Key Dates
| Date | Description |
|---|---|
| 02/05/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 05/11/2018 | Date Employee Stock Option was exercisable |
| 05/10/2024 | Expiration date of Employee Stock Option |
| 02/29/2024 | Date of stock option exercise and sale |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.